← Suzhou Huazhijie Telecom overview

Suzhou Huazhijie Telecom vs NAURA Technology: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Suzhou Huazhijie Telecom Co (603400.CG)

Q3 2026
▲2▼1

Huazhijie pivots to chip testing with Geliming acquisition

  • Weak first-half results Huazhijie's first-half 2026 net profit fell 46.78% and revenue dropped 3.60%, showing its core telecom components business is under pressure. Weak earnings weigh on the stock because investors see no near-term growth from the existing business.

    This explains the weak fundamental backdrop before the acquisition news.

  • Acquisition of Geliming announced On September 14, Huazhijie said it would buy 100% of Geliming Electronics, a semiconductor test fixture maker, using shares and cash. The stock hit its daily limit that day and trading was suspended, as investors bet the deal moves Huazhijie into a faster-growing chip-related business.

    This is the main new event that changed the company's story and drove the stock.

  • Deal terms and trading resumption On September 29, Huazhijie detailed the plan to buy 83.51% of Geliming at 39.08 yuan per share, a 28.5% discount to the last close, and said trading resumes September 30. The deal expands its precision components business into semiconductor testing, but the company warned of insider-trading risk that could delay or cancel it.

    This gives the concrete terms and the key risk that will shape the stock when it reopens.

August 2026
▲2▼1

Huazhijie pivots to chip testing with Geliming acquisition

  • Weak first-half results Huazhijie's first-half 2026 net profit fell 46.78% and revenue dropped 3.60%, showing its core telecom components business is under pressure. Weak earnings weigh on the stock because investors see no near-term growth from the existing business.

    This explains the weak fundamental backdrop before the acquisition news.

  • Acquisition of Geliming announced On September 14, Huazhijie said it would buy 100% of Geliming Electronics, a semiconductor test fixture maker, using shares and cash. The stock hit its daily limit that day and trading was suspended, as investors bet the deal moves Huazhijie into a faster-growing chip-related business.

    This is the main new event that changed the company's story and drove the stock.

  • Deal terms and trading resumption On September 29, Huazhijie detailed the plan to buy 83.51% of Geliming at 39.08 yuan per share, a 28.5% discount to the last close, and said trading resumes September 30. The deal expands its precision components business into semiconductor testing, but the company warned of insider-trading risk that could delay or cancel it.

    This gives the concrete terms and the key risk that will shape the stock when it reopens.

Latest
▲2▼1

Huazhijie pivots to chip testing with Geliming acquisition

  • Weak first-half results Huazhijie's first-half 2026 net profit fell 46.78% and revenue dropped 3.60%, showing its core telecom components business is under pressure. Weak earnings weigh on the stock because investors see no near-term growth from the existing business.

    This explains the weak fundamental backdrop before the acquisition news.

  • Acquisition of Geliming announced On September 14, Huazhijie said it would buy 100% of Geliming Electronics, a semiconductor test fixture maker, using shares and cash. The stock hit its daily limit that day and trading was suspended, as investors bet the deal moves Huazhijie into a faster-growing chip-related business.

    This is the main new event that changed the company's story and drove the stock.

  • Deal terms and trading resumption On September 29, Huazhijie detailed the plan to buy 83.51% of Geliming at 39.08 yuan per share, a 28.5% discount to the last close, and said trading resumes September 30. The deal expands its precision components business into semiconductor testing, but the company warned of insider-trading risk that could delay or cancel it.

    This gives the concrete terms and the key risk that will shape the stock when it reopens.

NAURA Technology Group Co Ltd (002371.CS)

Q3 2026
▲3▼1

NAURA Gains on AI Demand and China Chip Self-Reliance Push

  • AI chip demand and China self-reliance Strong AI chip demand and China's push for chip self-reliance drove NAURA's momentum. H1 2026 revenue rose 25% to 20.16 billion yuan, though profit grew only 5%, reflecting cost or mix pressures.

    This is the core positive driver of the stock's performance during the period.

  • Beijing's five-year plan and Western restrictions Beijing's new five-year plan prioritizes domestic chip equipment, and Western supply restrictions are pushing Chinese fabs toward 100% domestic tools, leaving NAURA's order backlog overflowing.

    This policy and geopolitical shift directly boosts NAURA's order book and outlook.

  • Record global equipment sales forecast SEMI forecasts record global equipment sales of $165.9 billion in 2026, supporting the outlook for NAURA as a key equipment supplier.

    This industry forecast underpins positive sentiment and growth expectations.

  • Market sell-offs and policy risks The stock fell 6.65% in one day amid a global AI sell-off and weak China PMI, and dropped ~3.3% on reports Beijing may allow Nvidia chip purchases and OpenAI's training pause. Modest profit growth may also limit earnings-driven upside.

    These events and concerns acted as a counterweight, causing sharp price drops.

August 2026
▲3▼1

NAURA Gains on AI Demand and China Chip Self-Reliance Push

  • AI chip demand and China self-reliance Strong AI chip demand and China's push for chip self-reliance drove NAURA's momentum. H1 2026 revenue rose 25% to 20.16 billion yuan, though profit grew only 5%, reflecting cost or mix pressures.

    This is the core positive driver of the stock's performance during the period.

  • Beijing's five-year plan and Western restrictions Beijing's new five-year plan prioritizes domestic chip equipment, and Western supply restrictions are pushing Chinese fabs toward 100% domestic tools, leaving NAURA's order backlog overflowing.

    This policy and geopolitical shift directly boosts NAURA's order book and outlook.

  • Record global equipment sales forecast SEMI forecasts record global equipment sales of $165.9 billion in 2026, supporting the outlook for NAURA as a key equipment supplier.

    This industry forecast underpins positive sentiment and growth expectations.

  • Market sell-offs and policy risks The stock fell 6.65% in one day amid a global AI sell-off and weak China PMI, and dropped ~3.3% on reports Beijing may allow Nvidia chip purchases and OpenAI's training pause. Modest profit growth may also limit earnings-driven upside.

    These events and concerns acted as a counterweight, causing sharp price drops.

Latest
▲3▼1

NAURA rides China chip self-reliance, but Nvidia and AI worries weigh

  • China's five-year plan backs domestic chip equipment Beijing's new 2026-2030 electronics plan makes integrated circuits and chipmaking equipment a priority, aiming for 30 trillion yuan in industry revenue. This policy support lifts NAURA, a key domestic equipment maker, as investors expect more government backing and orders.

    This is a major new policy catalyst that directly boosts demand for NAURA's products.

  • Chinese fabs rush to buy domestic tools, NAURA's orders overflow Western supply restrictions are pushing Chinese chip factories to buy 100% domestic equipment. NAURA's etching, deposition, and cleaning tools let fabs buy almost a full suite from one supplier, and its order backlog is overflowing. This strong demand supports future revenue and profit.

    It shows concrete, ongoing demand driving NAURA's order book, a core reason the stock is moving.

  • Nvidia sales report and OpenAI pause hit chip stocks Two late-September shocks hit chip shares: a report that Beijing may let firms buy Nvidia's advanced chips, and OpenAI pausing some AI training over safety. NAURA fell about 3.3-3.4% on each, as investors feared weaker demand for domestic equipment and a broader AI slowdown.

    These are the main negative forces this period, showing real counterweights to the positive policy and demand story.

  • First-half profit up 5%, but growth is modest NAURA reported first-half 2026 net profit of 3.37 billion yuan, up 5.05% from a year earlier. While still growing, the pace is slower than many peers, which may limit how much the stock can rally on earnings alone.

    It gives the fundamental earnings picture, showing growth but also a potential soft spot.

▲3▼1

NAURA's H1 profit up 5%, revenue up 25%, as AI chip demand drives equipment orders

  • H1 results: revenue up 25%, profit up 5% NAURA reported first-half revenue of 20.16 billion yuan, up 24.9%, and net profit of 3.37 billion yuan, up 5.05%. The slower profit growth reflects costs or mix, but rising market share in etching and deposition equipment shows the core business is expanding.

    The half-year report is the most important new company-specific event and directly shows financial performance.

  • AI and domestic chip push lift equipment demand InnovestX says AI is accelerating Chinese tech investment, with hyperscaler capex revised up sharply and domestic chip production set to rise. This boosts demand for NAURA's chipmaking equipment as China builds its own supply chain.

    This is a new analyst view explaining the big-picture demand driver for NAURA's products.

  • Global AI sell-off and weak China PMI hit tech stocks On August 3, a global sell-off in AI tech stocks and a drop in China's manufacturing PMI dragged NAURA down 6.65% in one day. This shows the stock remains sensitive to broad market and economic worries, even if the long-term story is intact.

    It is a new event that caused a sharp price drop and highlights a real risk factor.

  • SEMI record equipment sales forecast and analyst dip-buy calls SEMI forecasts global chip equipment sales to hit a record $165.9 billion in 2026, up 23.2%, and analysts recommend buying NAURA after the tech correction. This reinforces the view that equipment demand is strong and NAURA is a key beneficiary.

    It provides industry-level support and analyst endorsement that underpin the positive outlook.